StockData
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB) stock

MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.41+0.00 (0.00%)

Close on Nov 17, 2026Market cap $14.02MP/E –Yield –

Seres Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Seres Therapeutics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0, down 100.0% from the year before. The highest annual figure on record is $101.54M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$101.54M+100.7%
FY2022Dec 31, 2022$50.59M+105.3%
FY2021Dec 31, 2021$24.64M+0.0%
FY2020Dec 31, 2020$24.64M-0.0%
FY2019Dec 31, 2019$24.65M+1790.2%
FY2014Dec 31, 2014$1.30M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$102.49M+1.7%
Q1 FY2024Mar 31, 2024$102.01M+99.1%
Q4 FY2023Dec 31, 2023$101.54M+100.7%
Q3 FY2023Sep 30, 2023$101.14M+98.9%
Q2 FY2023Jun 30, 2023$100.74M+99.0%
Q1 FY2023Mar 31, 2023$51.23M+1.6%
Q4 FY2022Dec 31, 2022$50.59M+105.3%
Q3 FY2022Sep 30, 2022$50.86M+215.5%
Q2 FY2022Jun 30, 2022$50.63M+166.0%
Q1 FY2022Mar 31, 2022$50.44M+130.6%
Q4 FY2021Dec 31, 2021$24.64M+0.0%
Q3 FY2021Sep 30, 2021$16.12M-35.5%
Q2 FY2021Jun 30, 2021$19.04M-23.4%
Q1 FY2021Mar 31, 2021$21.87M-11.6%
Q4 FY2020Dec 31, 2020$24.64M-0.0%
Q3 FY2020Sep 30, 2020$24.98M–
Q2 FY2020Jun 30, 2020$24.86M–
Q1 FY2020Mar 31, 2020$24.75M–
Q4 FY2019Dec 31, 2019$24.65M–

More Seres Therapeutics figures

See a number that looks wrong?